FIELD: medicine.
SUBSTANCE: invention represents a pharmaceutical composition for treating local manifestations of herpes simplex infections and for preventing influenza and acute respiratory viral infections, containing green tea extract and epigallocatechin-3-gallate (EGCG) 70-90 wt %, colloidal silver and a gel-forming base with the ingredients of the composition taken in certain ratio, wt %.
EFFECT: high clinical effectiveness.
6 cl, 8 ex, 5 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PRODUCING PROPHYLACTIC ANTIVIRAL COMPOSITION BASED ON EPIGALLOCATECHIN-3-GALLATE (EGCG) | 2021 |
|
RU2771898C1 |
| PHARMACEUTICAL COMPOSITION BASED ON EPIGALLOCATECHINEGALLATE-CONTAINING NANOMICELLES AND ITS APPLICATION FOR TREATMENT OF ATOPIC DERMATITIS, CROHN'S DISEASE, ADENOMYOSIS AND HYPERPLASTIC DISEASES OF PROSTATE | 2011 |
|
RU2465912C9 |
| PHARMACEUTICAL COMPOSITION FOR TREATMENT OF DYSPLASTIC PROCESSES OF CERVIX | 2008 |
|
RU2395281C2 |
| DIINDOLYLMETHANE DRUG PREPARATION AND USING IT FOR TREATING INFLUENZA AND RESPIRATORY VIRAL INFECTIONS | 2013 |
|
RU2537025C1 |
| PHARMACEUTICAL COMPOSITION FOR TREATMENT AND PROPHYLAXIS OF GENITAL HERPES, CHRONIC PAPILLOMA OF VIRAL INFECTION AND PROPHYLAXIS OF UTERINE CERVIX CANCER (VARIANTS) | 2000 |
|
RU2180593C1 |
| PHARMACEUTICAL COMPOSITION FOR TREATMENT OF HERPES VIRAL INFECTION | 2003 |
|
RU2241443C1 |
| IMMUNOMODULATORY DRUG IN SECONDARY IMMUNODEFICIENCY STATES | 2008 |
|
RU2375072C1 |
| PHARMACEUTICAL COMPOSITION FOR ADENOMYOSIS TREATMENT AND PREVENTION | 2009 |
|
RU2406497C1 |
| METHOD OF TREATMENT FOR GENITAL HERPES | 2007 |
|
RU2339377C1 |
| PHARMACEUTICAL COMPOSITION FOR TREATMENT AND PROPHYLAXIS OF PROLIFERATIVE DISEASES | 2004 |
|
RU2276993C2 |
